NCR1 and neoplasm: NK cells similarly acquire tumor antigens or co-stimulatory receptors like NKp46 and NKG2D via trogocytosis, potentially enhancing cytotoxicity and tumor-homing capacity (Domaica et al., 2009; Ramezani et al., 2023).